Optimization of Xenografting Methods for Generating Human Skeletal Muscle in Mice

Cell Transplant. 2024 Jan-Dec:33:9636897241242624. doi: 10.1177/09636897241242624.

Abstract

Xenografts of human skeletal muscle generated in mice can be used to study muscle pathology and to test drugs designed to treat myopathies and muscular dystrophies for their efficacy and specificity in human tissue. We previously developed methods to generate mature human skeletal muscles in immunocompromised mice starting with human myogenic precursor cells (hMPCs) from healthy individuals and individuals with facioscapulohumeral muscular dystrophy (FSHD). Here, we examine a series of alternative treatments at each stage in order to optimize engraftment. We show that (i) X-irradiation at 25Gy is optimal in preventing regeneration of murine muscle while supporting robust engraftment and the formation of human fibers without significant murine contamination; (ii) hMPC lines differ in their capacity to engraft; (iii) some hMPC lines yield grafts that respond better to intermittent neuromuscular electrical stimulation (iNMES) than others; (iv) some lines engraft better in male than in female mice; (v) coinjection of hMPCs with laminin, gelatin, Matrigel, or Growdex does not improve engraftment; (vi) BaCl2 is an acceptable replacement for cardiotoxin, but other snake venom preparations and toxins, including the major component of cardiotoxin, cytotoxin 5, are not; and (vii) generating grafts in both hindlimbs followed by iNMES of each limb yields more robust grafts than housing mice in cages with running wheels. Our results suggest that replacing cardiotoxin with BaCl2 and engrafting both tibialis anterior muscles generates robust grafts of adult human muscle tissue in mice.

Keywords: X-irradiation; electrical stimulation; exercise; immortalized muscle cells; myotoxin.

MeSH terms

  • Adult
  • Animals
  • Cardiotoxins*
  • Female
  • Heterografts
  • Humans
  • Male
  • Mice
  • Muscle, Skeletal / pathology
  • Muscular Dystrophy, Facioscapulohumeral* / pathology
  • Transplantation, Heterologous

Substances

  • Cardiotoxins